ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1183

Podoplanin-Mediated Interaction of Rheumatoid Arthritis Synovial Fibroblasts with Platelets Modulates IL-8 Expression

Manuel J. Del Rey1, Elena Izquierdo1, Regina Faré1, Alicia Usategui1, Vanessa Miranda1, Gabriel Criado2, J. D. Cañete3 and Jose L. Pablos1, 1Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 3Unitat d'Artritis, Servei de Reumatologia, Hospital Clínic de Barcelona,, Barcelona, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines, fibroblasts and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumamtoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Synovial fibroblasts (SF) are the most abundant resident stromal cells in the synovium. In rheumatoid arthritis (RA), SF expand and undergo phenotypic changes that contribute to the pathogenesis of chronic arthritis. Among these changes, expression of podoplanin, a membrane protein expressed by normal lymphatic endothelium and cancer cells, has been reported (Ekwall, Arthritis Res Ther 2011). Podoplanin is up-regulated on the invasive front of tumors and participates in tumor cell migration. The only known specific receptor for podoplanin is the platelet membrane signaling protein CLEC-2. We have analyzed the expression and potential functions of podoplanin in rheumatoid arthritis synovial fibroblasts (RASF). 

Methods: Podoplanin expression was analyzed by immunohistochemistry (IHC), immunofluorecence labeling (IF), quantitative real-time polymerase chain reaction (qRT-PCR) and flow cytometry in synovial tissue and SF cultures from RA and osteoarthritis (OA) patients and healthy donors. Podoplanin RASF expression was silenced with podoplanin specific and control siRNA lentiviral expression vectors. Transduced cells were used in RASF-cartilage co-culture experiment to measure cartilage glycosaminoglycan degradation products in supernatants (Blyscan Assay; Biocolor, Northern Ireland, UK). Matrigel invasion and in vitro wound healing assays were performed to evaluate migration capability of silenced fibroblasts. Finally, silenced RASF were co-cultured for 24h with human platelets prepared from healthy donors and RASF RNA was extracted to quantify IL-6, IL-8, MCP-1, MMP-1 and MMP-3 mRNA expression by qRT-PCR. Quantitative data from at least three independent experiments were analyzed by Mann-Whitney U-test or t-test as required and p-value<0.05 was considered significant.

Results:

Abundant podoplanin expression was detected by IHC in synovial lining and sublining fibroblasts in RA biopsies (n=40) whereas minimal or absent expression was observed in OA (n=15) or healthy synovium (n=6) respectively. Cultured SF displayed abundant podoplanin membrane expression irrespective of their source (RA, OA or healthy synovium). Treatment of cultured SF with TNF-α induced up-regulation of podoplanin mRNA and protein expression, as determined by qRT-PCR and flow cytometry. Podoplanin expression was effectively down-regulated by specific siRNA lentiviral transduction. Cell migration in matrigel and wound healing assays and ex vivo cartilage degradation were not modified in RASF transduced with podoplanin siRNA compared to RASF transduced with scrambled control siRNA. Co-culture of RASF with platelets induced a significant increase in IL-6 and IL-8 but no MCP-1, MMP-1 or MMP-3 mRNA expression in RASF. siRNA podoplanin silencing in RASF blocked the up-regulation of IL-8 but not IL-6 mRNA expression in response to platelet co-culture. 

Conclusion: Our results confirm previous data on the up-regulation of podoplanin in RASF. Functional studies do not support a role for podoplanin on RASF migratory and invasive properties as reported in cancer cells. Podoplanin is potentially involved in the pro-inflammatory response that results from RASF/platelet interaction.


Disclosure:

M. J. Del Rey,
None;

E. Izquierdo,
None;

R. Faré,
None;

A. Usategui,
None;

V. Miranda,
None;

G. Criado,
None;

J. D. Cañete,
None;

J. L. Pablos,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/podoplanin-mediated-interaction-of-rheumatoid-arthritis-synovial-fibroblasts-with-platelets-modulates-il-8-expression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology